Goldman Launches Merck KGaA With ‘Buy’ – Ziel 205 Euro

NEW YORK (dpa-AFX Analyser) – The American investment bank Goldman Sachs has accepted the agreement of Merck KGaA with a price of 205 euros with “Buy” recommendations. Analyst James Quigley has made a first analysis with a holistic period in one of the Donnerstag rounds. It is clear that a study has been made in the Life-Science studies of the chemical and pharmaceutical industry, very by a solid foundation in pharmaceuticals and in the development of the electronics industry./tih/agOpening of the original study: 19.09.2024 / 05:00 / BST

NEW: 57. Activated Auflage:
>250,000 Read: Der Leitfaden für Ihr Power!
Order here for free …

Erstmalige Weitergabe der Original-Studie: Datum in Studie nicht gegeben / Uhrzeit in Studie nicht gegeben / Zeitzone in Studie nicht gegeben

Note: Information about Offenlegungspflicht bei Interessenkonflikten im Sinne von § 85 Abs. 1 WpHG, art. 20 VO (EU) 596/2014 for the generated analyst house can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.

Source: dpa-AFX

PS: Merck KGaA is a Champions-Action on the boerse.de-Aktienbrief. You can download the active Aktienbrief-Ausgabe here for free. Merck KGaA is currently included in the boerse.de-Dividendenfonds. In total, the boerse.de-Fund with 3,917 shares is invested in a value of 648,851 euros. You can find more information about the boerse.de-Fund here or in the Leifaden voor ihr Vermögen.